Steroid Dose for RA-Associated Pleurisy

Initial Dosing Strategy

The American College of Rheumatology suggests starting with 20-30 mg prednisone daily for pleuritic manifestations, as this falls within the medium-dose range (>7.5 mg but ≤100 mg daily) appropriate for extra-articular RA complications 1
Doses >30 mg/day should be avoided unless evaluating for alternative diagnoses, as higher doses lack evidence of benefit and carry substantial harm 2, 3
Low doses (≤7.5 mg/day) are insufficient for acute serositis and should be discouraged as initial therapy 2, 3

RA pleurisy represents moderate-severity extra-articular disease requiring more aggressive initial treatment than articular symptoms alone 1
The CDC defines immunosuppression threshold at 20 mg prednisone daily for ≥2 weeks, and observational data show increased infection risk with long-term use >15 mg/day 4, 5
Medium-dose glucocorticoids (>7.5 mg but ≤100 mg daily) generate both genomic and non-genomic effects necessary for controlling serositis 1

Reduce to 10 mg/day within 4-8 weeks of symptom control, then taper by 1 mg every 2-4 weeks once below 10 mg/day 6

Initiate or optimize methotrexate or other DMARDs simultaneously with glucocorticoid therapy, as this provides steroid-sparing effects 7, 2, 6

Use single daily morning dosing rather than divided doses for most patients 2, 3
Consider divided dosing only if prominent nighttime pleuritic pain persists during tapering below 5 mg/day 2, 3

Optimize glucocorticoid dose to <20 mg/day as quickly as possible to minimize infection risk 4, 5

Do not continue moderate doses (>10 mg/day) beyond 4-8 weeks without reassessing for alternative diagnoses or inadequate DMARD therapy 1, 6
Avoid abrupt discontinuation after prolonged use, as this risks adrenal insufficiency 1